SYNERGY Stent, Durable-Polymer Stents Show Similar Outcomes in TWILIGHT Substudy
The SYNERGY bioabsorbable-polymer (BP) drug-eluting stent (DES) showed similar clinical outcomes to durable-polymer (DP) DES in high-risk patients undergoing percutaneous coronary intervention (PCI), according to a substudy of the TWILIGHT trial.